Abstract
The adhesion of cells to vertically aligned TiO2 nanotubes is reviewed. The attraction between a negatively charged nanotube surface and a negatively charged osteoblast is facilitated by charged protein-mediators like proteins with a quadrupolar internal charge distribution, fibronectin and vitronectin. It is shown that adhesion and spreading of osteoblasts on vertically aligned TiO2 nanotube surfaces depend on the diameter of the nanotubes. Apparently, a small diameter nanotube surface has on average more sharp convex edges per unit area than a large one, leading to stronger binding affinity on its surface.
Keywords: TiO2 nanotube surfaces, adhesion, dynamic simulations, nanostructured surface topography, osteoblast adhesion
Mini-Reviews in Medicinal Chemistry
Title:Adhesion of Osteoblasts to a Vertically Aligned TiO2 Nanotube Surface
Volume: 13 Issue: 2
Author(s): Ekaterina Gongadze, Doron Kabaso, Sebastian Bauer, Jung Park, Patrik Schmuki and Ales Iglic
Affiliation:
Keywords: TiO2 nanotube surfaces, adhesion, dynamic simulations, nanostructured surface topography, osteoblast adhesion
Abstract: The adhesion of cells to vertically aligned TiO2 nanotubes is reviewed. The attraction between a negatively charged nanotube surface and a negatively charged osteoblast is facilitated by charged protein-mediators like proteins with a quadrupolar internal charge distribution, fibronectin and vitronectin. It is shown that adhesion and spreading of osteoblasts on vertically aligned TiO2 nanotube surfaces depend on the diameter of the nanotubes. Apparently, a small diameter nanotube surface has on average more sharp convex edges per unit area than a large one, leading to stronger binding affinity on its surface.
Export Options
About this article
Cite this article as:
Gongadze Ekaterina, Kabaso Doron, Bauer Sebastian, Park Jung, Schmuki Patrik and Iglic Ales, Adhesion of Osteoblasts to a Vertically Aligned TiO2 Nanotube Surface, Mini-Reviews in Medicinal Chemistry 2013; 13 (2) . https://dx.doi.org/10.2174/1389557511313020002
DOI https://dx.doi.org/10.2174/1389557511313020002 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress in the Development of Melanocortin Receptor Selective Ligands
Current Pharmaceutical Design Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Biologics for the Treatment of Juvenile Idiopathic Arthritis
Current Medicinal Chemistry Controversies in the Pharmacological Treatment of Uveitis
Current Pharmaceutical Design Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets A Valuable Animal Model of Spinal Cord Injury to Study Motor Dysfunctions, Comorbid Conditions, and Aging Associated Diseases
Current Pharmaceutical Design New Insights in Congenital Diaphragmatic Hernia
Current Respiratory Medicine Reviews Targeting the Platelet Integrin GPIIb/IIIa
Current Pharmaceutical Design Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Interferons: Mechanisms, Biological Activities and Survey of their Use in Human Diseases
Current Bioactive Compounds Comparative Efficacy and Safety of Duration of Dual Antiplatelet Therapy in Patients with CAD Undergoing Drug-eluting Stent Implantation: A Systematic Review and Network Meta-analysis
Current Pharmaceutical Design Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Current Pharmaceutical Design Basic Symptoms and the Prediction of First-Episode Psychosis
Current Pharmaceutical Design Lipids and Lysosomes
Current Drug Metabolism Glycosphingolipid Structure and Function in Membranes
Current Organic Chemistry Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Current Drug Abuse Reviews Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter
Current Enzyme Inhibition Biotherapy for Autoimmune Liver Diseases
Current Pharmaceutical Biotechnology Genetics of Bladder Malignant Tumors in Childhood
Current Genomics